{"pub": "marketwatch", "url": "https://marketwatch.com/story/allergan-to-book-750-million-pre-tax-charge-in-q3-after-settlement-of-navenda-class-action-suit-2019-10-28", "downloaded_at": "2019-10-28 13:28:31.485898+00:00", "title": "Allergan to book $750 million pre-tax charge in Q3 after settlement of Navenda class-action suit", "language": "en", "text": "Botox maker Allergan Plc AGN, -0.05% said Monday it expects to book a pre-tax charge of $750 million in the third quarter after its Forest subsidiaries settled an antitrust class action suit brought by direct purchasers of Namenda, a treatment for dementia associated with Alzheimer's disease. Forest will pay that sum to settle the suit, which was scheduled to go to trial in October. Forest became a wholly owned unit of Actavis Plc in June 2014, after which Actavis changed its name to Allergan. Allergan shares were slightly higher premarket but have gained 30% in 2019, while the S&P 500 SPX, +0.41% has gained 21%.", "description": "Botox maker Allergan Plc said Monday it expects to book a pre-tax charge of $750 million in the third quarter after its Forest subsidiaries settled an...", "authors": ["Ciara Linnane", "Corporate News Editor"], "top_image": "https://mw3.wsj.net/mw5/content/logos/mw_logo_social.png", "published_at": "2019-10-28"}